Product Information
OMEPRAZOLE-BICARB 40-1,680 PKT is a generic product labeled by Oceanside Pharmaceuticals, priced at $10.1462 per EA under NDC 68682099130. Its NADAC has been published 172 times since May 22, 2019.
FDA first approved this application on Jun 15, 2004.
Strength
40; 1680 mg/1; mg/1
Manufacturer
Oceanside PharmaceuticalsNDC
68682099130
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
OMEPRAZOLE; SODIUM BICARBONATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021636FDA Approved
6/15/2004
On Market Since
6/15/2004
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has been published 172 times since May 22, 2019, and over the history we have for it it has declined 50.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.1462 per EA |
|---|---|
| All-time high | $20.4936 (Sep 11, 2019) |
| All-time low | $9.4323 (Jul 23, 2025) |
| Median price | $15.6386 |
| Average price | $15.6120 |
| Largest weekly change | -28.8% (Dec 20, 2023) |
| Weeks tracked | 172 |
| Tracking since | May 22, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-45.2%
5Y
-45.2%
All
-50.5%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the omeprazole, sodium bicarbonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
omeprazole, sodium bicarbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEPRAZOLE-BICARB 40-1,680 PKT?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE-BICARB 40-1,680 PKT, manufactured by Oceanside Pharmaceuticals, is $10.1462 per EA (NDC 68682099130), effective Oct 1, 2025.
How has the price of OMEPRAZOLE-BICARB 40-1,680 PKT changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has declined 50.5%. It has been tracked across 172 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE-BICARB 40-1,680 PKT?
Since May 22, 2019, the NADAC for OMEPRAZOLE-BICARB 40-1,680 PKT has ranged from a low of $9.4323 (Jul 23, 2025) to a high of $20.4936 (Sep 11, 2019), with a median of $15.6386 per EA.
Are there cheaper alternatives to OMEPRAZOLE-BICARB 40-1,680 PKT?
No other NADAC-published product currently shares the active ingredient and strength of OMEPRAZOLE-BICARB 40-1,680 PKT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OMEPRAZOLE-BICARB 40-1,680 PKT?
OMEPRAZOLE-BICARB 40-1,680 PKT (NDC 68682099130) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.